logo

MDAI

Spectral AI
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
Signals Analysis
Buy signal 1
Sell signal 2
consensus rating "Strong Buy"
EPS Below Expectations
Revenue Below Expectations

Key Stats

--DAY`S RANGE--
--52 WK RANGE--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--

About MDAI

Spectral Ai, Inc.

A Special Purpose Acquisition Company

Healthcare Technology
11/17/2020
04/06/2021
NASDAQ Stock Exchange
78
12-31
Common stock
2515 McKinney Avenue, Suite 1000, Dallas, Texas 75201
--
Spectral AI, Inc., was incorporated in Delaware on November 17, 2020. The company is an artificial intelligence company focused on predictive medical diagnosis. The company is putting a lot of effort into the development of DeepView System, an in-house developed AI-powered MSI device that has FDA BDD status since 2018. The company's DeepView System uses a proprietary AI algorithm to distinguish completely damaged, partially damaged and invisible healthy human tissue features, providing a "Day One" healing potential assessment in seconds. DeepView's output is specially designed to allow doctors to make more accurate, timely and informed decisions about the treatment of patients' wounds.

Company Financials

EPS

MDAI has released its 2024 Q4 earnings. EPS was reported at -0.41, versus the expected -0.14, missing expectations. The chart below visualizes how MDAI has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

MDAI has released its 2024 Q4 earnings report, with revenue of 7.60M, reflecting a YoY change of 43.82%, and net profit of -7.74M, showing a YoY change of -118.33%. The Sankey diagram below clearly presents MDAI’s revenue sources and cost distribution.

Forecast

Wall Street Opinions

Price Target

Volume Profile

Trade Flow Insight

Seasonals

Community Forum

Loading...

Related News

No articles available

Related Symbols

You can ask Aime